Tilray Inc – Class 2 (NASDAQ:TLRY) Can’t Be More Risky. Short Interest Increased

October 13, 2018 - By Darrin Black

The stock of Tilray Inc – Class 2 (NASDAQ:TLRY) registered an increase of 96.96% in short interest. TLRY’s total short interest was 3.50M shares in October as published by FINRA. Its up 96.96% from 1.78M shares, reported previously. With 8.40 million shares average volume, it will take short sellers 0 days to cover their TLRY’s short positions.

The stock increased 12.39% or $16.35 during the last trading session, reaching $148.3. About 4.19M shares traded. Tilray, Inc. (NASDAQ:TLRY) has 0.00% since October 13, 2017 and is . It has underperformed by 15.62% the S&P500.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company has market cap of $13.81 billion. The firm offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. It currently has negative earnings.

More notable recent Tilray, Inc. (NASDAQ:TLRY) news were published by: Seekingalpha.com which released: “The Tilray Bubble Is Bound To Burst” on September 17, 2018, also Seekingalpha.com with their article: “Tilray: The Madness Is Not Over Yet” published on October 02, 2018, Fool.ca published: “Canopy Growth Corp (TSX:WEED) vs. Tilray Inc (NASDAQ:TLRY): Which Is the True Cannabis King?” on October 09, 2018. More interesting news about Tilray, Inc. (NASDAQ:TLRY) were released by: Seekingalpha.com and their article: “Tilray acquires Alef Biotechnology” published on October 09, 2018 as well as Seekingalpha.com‘s news article titled: “Tilray: Pump And Dump Or Short Squeeze?” with publication date: October 04, 2018.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.